Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (54 ops.)
Latest filing published 26 Apr 2013 for INVITROGEN CORP, €212k.
Insider track record
Disclosed buys
0
Disclosed sells
54
Signal history
No signal scores available.
Bradley G. Lorimier: trading record in brief
Bradley G. Lorimier discloses dealings in 2 companies, chiefly Invitrogen Corp and Avalon Pharmaceuticals Inc. We count 69 filings; the first trade dates from 22 February 2007 and the latest from 25 April 2013.
The open-market record consists of 54 sales worth €3.2M, with no purchase. Outside the open market, there are 14 option exercises.
The latest filing, published on 26 April 2013, reports an option exercise of €277k in Invitrogen Corp. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Bradley G. Lorimier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations65 total
3,742 shares@ US$73.70Common StockSEC:0001127602-13-014621:0
2,000 shares@ US$73.70Common StockSEC:0001127602-13-014621:1
4,052 shares@ US$73.70Common StockSEC:0001127602-13-014621:3
4,888 shares@ US$73.70Common StockSEC:0001127602-13-014621:5
5,228 shares@ US$73.70Common StockSEC:0001127602-13-014621:7
20,000 shares@ US$15.04Common StockSEC:0001127602-12-033665:0
1,500 shares@ US$51.04Common StockSEC:0001127602-12-033665:1
7,800 shares@ US$51.04Common StockSEC:0001127602-12-033665:2
200 shares@ US$51.05Common StockSEC:0001127602-12-033665:3
2,001 shares@ US$51.06Common StockSEC:0001127602-12-033665:4
2,299 shares@ US$51.07Common StockSEC:0001127602-12-033665:5
4,000 shares@ US$51.07Common StockSEC:0001127602-12-033665:6
2,200 shares@ US$51.11Common StockSEC:0001127602-12-033665:7
20,000 shares@ US$17.56Common StockSEC:0001127602-12-015817:0
17,216 shares@ US$46.48Common StockSEC:0001127602-12-015817:1
2,784 shares@ US$46.95Common StockSEC:0001127602-12-015817:2
11,661 shares@ US$33.31Common StockSEC:0001127602-11-000809:0
280 shares@ US$56.35Common StockSEC:0001127602-11-000809:1
100 shares@ US$56.35Common StockSEC:0001127602-11-000809:2
300 shares@ US$56.35Common StockSEC:0001127602-11-000809:3
500 shares@ US$56.34Common StockSEC:0001127602-11-000809:4
100 shares@ US$56.33Common StockSEC:0001127602-11-000809:5
100 shares@ US$56.29Common StockSEC:0001127602-11-000809:6
300 shares@ US$56.27Common StockSEC:0001127602-11-000809:7
100 shares@ US$56.25Common StockSEC:0001127602-11-000809:8
25 of 65 declarations
